MENU

HIMS Stock Hims & Hers Health (HIMS, $37.09) Stochastic Oscillator left the oversold zone on November 25, 2025

A.I.dvisor
at Tickeron.com
Loading...
HIMS - Hims & Hers Health
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $37.09
Daily change: -$0.69 (-1.83%)
Daily volume: 14.4M
Capitalization: $8.4B
Industry: Pharmaceuticals: Generic

This is a signal that HIMS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 60 similar cases where HIMS's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

HIMS's RSI Oscillator ascends from oversold territory

The RSI Indicator for HIMS moved out of oversold territory on November 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where HIMS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HIMS just turned positive on November 25, 2025. Looking at past instances where HIMS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMS advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

HIMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

HIMS moved below its 50-day moving average on October 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HIMS crossed bearishly below the 50-day moving average on October 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIMS entered a downward trend on November 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HIMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.535) is normal, around the industry mean (16.491). P/E Ratio (69.981) is within average values for comparable stocks, (72.893). Projected Growth (PEG Ratio) (2.100) is also within normal values, averaging (1.950). HIMS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (4.255) is also within normal values, averaging (55.675).

View a ticker or compare two or three
HIMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HIMS showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which is involved in real estate investment trusts

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2269 Chestnut Street
Phone
+1 415 851-0195
Employees
658
Web
https://www.forhims.com